glp-1 drugs chemically different clinically similar Receptor Agonists Most people have heard of

For Indian pharma, the question is whether they are positioned to ride that wave or get swamped by it

Before starting treatment, it is important to understand your insurance benefits and prescription coverage

Readers are encouraged to verify all details directly with SynergyRx and their healthcare provider before making decisions

To date, more than a dozen GLP-1 drugs have been launched globally

In this study, with a median follow-up of 25 months, the primary composite end point including cardiovascular death, MI, stroke, and hospitalization for unstable angina occurred in 406 patients (13.4%) in the lixisenatide group and in 399 (13.2%) in the placebo group (HR, 1.02

Microdosing involves using doses below manufacturer-recommended levels without supporting clinical trial data on efficacy or safety